LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult ...

LEO Pharma Unveils Most Extensive EADV Program To Date with 5 Late Breaking Abstracts and 23 Posters Sharing Clinical and ...

Jefferies analyst Michael Yee in a note to investors called rocatinlimab’s atopic dermatitis data “modest,” noting that the ...

"A majority of adults in the U.S. have self-described sensitive skin and over 100 million people in the U.S. suffer from acne ...

Seen, the hair care brand developed by Harvard-trained dermatologist Dr. Iris Rubin after she experienced breakouts that were traced back to her hair care products, has closed a $9 million Series A ...

September is Eczema Awareness Month - and if you've any experience with the condition you'll know just how debilitating it can be.

ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of ...

New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing ...

Eli Lilly presents promising long-term data showing Ebglyss' efficacy in treating moderate-to-severe atopic dermatitis, with over 80% of patients maintaining clear skin for up to three years. FDA and ...

Galderma today announced that it will present new data from the ARCADIA and OLYMPIA clinical trial programs investigating ...

For Bazaar's "Take the Edge Off" series, we break down the beauty and wellness must-haves supermodel Georgia May Jagger ...